Personalized Medicine Market, by Product (Personalized Medicine Diagnostics, Personalized Medical Care), by Application (Infectious Diseases, Blood Transfusion Safety, Cardiovascular Diseases), and geography Technology, and Forecast till 2027
Report ID : QR1001272 | Industries : Healthcare | Published On :November 2021 | Page Count : 263Personalized Medicine Market
A type of treatment that focuses on the individual physiognomies of each patient called as Personalized medicine. The perception of personalized medicine has developed with increasing advances in genomic and proteomic science over the past decade that has given a lift to the progress of “targeted” diagnostics and therapeutics that influence knowledge of an individual’s genetic makeup to construct a more personalized method to healthcare.
Market Drivers
The recent development in technologies like ultra-high-throughput sequencing and next-generation sequencing are the main driving factor of the growth of the market. The increasing number of companion diagnostics can be further accredited to the market growth. Also, the rising development of genomic medicines and biopharmaceuticals based on specific sequencing data can drive the market growth. The rising dominance of various types of cancer, affordability of personalized medicine therapy in cancer drugs, and numerous other disease indications are expected to drive the growth of market for Personalized Medicine in the global market.
Know more about this report: request for sample pages
Market Restraints
The precision medicine market is confidently progressing to greater heights, but the increased costs of diagnosis can hamper the Personalized Medicine market potential. The diagnosis and treatment process includes a huge amount of personal data, and there is a potential risk related to it that can compel the growth of the market. Also, one of the restraints of the market is the lack of awareness about genetic diseases and applications of personalized medicines among people.
Market Segmentation
The Personalized medicine market is segregated into different parts on the basis Product, Application and Region. On the basis of Product, the market is bifurcated in to Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Nutrition & Wellness, Personalized Medical Care. On the basis of Application, the market is bifurcated in to Cancer Management, Infectious Diseases, Central Nervous System (CNS) Disorders, Blood Transfusion Safety, Coagulation Therapy, Autoimmune Diseases, Cardiovascular Diseases, Neurology, And Psychiatry. On the basis of region, the market is bifurcated in to North America, Latin America, Europe, Asia Pacific, Middle East & Africa.
Regional Analysis
The Americas will hold the mainstream share in the worldwide market. The US personalized medicine market share will be the maximum developing one in the global market growth, and the progressive gene mapping technologies will support to expand the US personalized medicine market size. The European region has improved diagnostics tools, drugs, and electronic health care records, that will make this region second-largest shareholder of the market. The Asia Pacific region, will observe the growth in the market because of the increased disposable income and better healthcare infrastructure are available there.
Market Key Players
Some of the key players of the Personalized Medicine Market are Illumina, Inc., GE Healthcare, Danaher Corporation (Cepheid, Inc.), Abbott, QIAGEN, Exact Sciences Corporation, ASURAGEN, INC. Biogen, Dako A/S, Exagen Inc., Precision Biologics, Celera Diagnostics LLC, Decode Genetics, Inc., Genelex
Industry development
- In January 2020, the U.S. FDA approved avapritinib for treating patients with unresectable or metastatic Gastrointestinal Stromal Tumor (GIST). It is the first therapy approved for patients with GIST having PDGFRA exon 18 mutation.
- in February 2021, Illumina, Inc. signed an agreement with the Belgian Society of Medical Oncology (BSMO) for a national-level pilot program aimed at evaluating Comprehensive Genomic Profiling (CGP) in advanced metastatic cancer patients.
- In June 2020, Infosys launched an all-new, Personalized Medicine solution for the pharmaceutical industry. The solution leverages SAP S/4HANA, the SAP C/4HANA suite, the SAP Analytics Cloud solution, and the SCI platform to derive intelligent insights, enabling pharmaceutical companies to address critical business and regulatory requirements, while delivering personalized experiences to patients.
Personalized Medicine Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Personalized Medicine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Personalized Medicine Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Personalized Medicine Market Share Analysis, By Product
5.3 Personalized Medicine Market Size and Forecast, By Product
5.3.1 Personalized Medicine Diagnostics
5.3.2 Personalized Medicine Therapeutics
5.3.3 Personalized Nutrition & Wellness
5.3.4 Personalized Medical Care
6 Personalized Medicine Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Personalized Medicine Market Share Analysis, By Application
6.3 Personalized Medicine Market Size and Forecast, By Application
6.3.1 Cancer Management
6.3.2 Infectious Diseases
6.3.3 Central Nervous System (CNS) Disorders
6.3.4 Blood Transfusion Safety
6.3.5 Coagulation Therapy
6.3.6 Autoimmune Diseases
6.3.7 Neurology and Psychiatry
6.3.8 Cardiovascular Diseases
7 Personalized Medicine Market, By Region
7.1 Personalized Medicine Market Share Analysis, By Region
7.2 Personalized Medicine Market Share Analysis, By Region
7.3 Personalized Medicine Market Size and Forecast, By Region
8 North America Personalized Medicine Market Analysis and Forecast (2021 – 2027)
8.1 Introduction
8.2 North America Personalized Medicine Market Share Analysis, By Product
8.3 North America Personalized Medicine Market Size and Forecast, By Application
8.4 North America Personalized Medicine Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9 Europe Personalized Medicine Market Analysis and Forecast (2021 – 2027)
9.1 Introduction
9.2 Europe Personalized Medicine Market Share Analysis, By Product
9.3 Europe Personalized Medicine Market Size and Forecast, By Application
9.4 Europe Personalized Medicine Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Personalized Medicine Market Analysis and Forecast (2021 – 2027)
10.1 Introduction
10.2 Asia Pacific Personalized Medicine Market Share Analysis, By Product
10.3 Asia Pacific Personalized Medicine Market Size and Forecast, By Application
10.4 Asia Pacific Personalized Medicine Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Personalized Medicine Market Analysis and Forecast (2021 – 2027)
11.1 Introduction
11.2 Latin America Personalized Medicine Market Share Analysis, By Product
11.3 Latin America Personalized Medicine Market Size and Forecast, By Application
11.4 Latin America Personalized Medicine Market Size and Forecast, By Country
11.4.1. Brazil
11.4.2. Rest of Latin America
12 Middle East Personalized Medicine Market Analysis and Forecast (2021 – 2027)
12.1 Introduction
12.2 Middle East Personalized Medicine Market Share Analysis, By Product
12.3 Middle East Personalized Medicine Market Size and Forecast, By Application
12.4 Middle East Personalized Medicine Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Illumina, Inc.
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 GE Healthcare
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Danaher Corporation (Cepheid, Inc.)
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Abbott
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 QIAGEN
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Exact Sciences Corporation
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 ASURAGEN, INC. Biogen
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Dako A/S, Exagen Inc.
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Precision Biologics
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Celera Diagnostics LLC
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
14.11 Decode Genetics, Inc.
14.11.1 Overview
14.11.2 Offerings
14.11.3 Key Financials
14.11.4 Business Segment & Geographic Overview
14.11.5 Key Market Developments
14.11.6 Key Strategies
14.12 Genelex
14.12.1 Overview
14.12.2 Offerings
14.12.3 Key Financials
14.12.4 Business Segment & Geographic Overview
14.12.5 Key Market Developments
14.12.6 Key Strategies